MTOR and cervical cancer: Other reports propose that MNX1-AS1 can directly or indirectly influence major signaling pathways including Jak/Stat3 and Akt/mTOR in breast cancer [22, 35], MAPK in cervical cancer [24] and also possibly Notch in LSCC [36].